IncFact
Company Profiles: Revenue, Growth, Competition

Lucy Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing

Company Profile & Annual Report for Lucy Therapeutics

Access the complete profile.

Lucy Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address21 Hickory Drive, Suite 2b
Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Lucy Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Lucy Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Lucy Therapeutics Annual Revenue and Growth Rate

Lucy Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $1 - $10 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Lucy Therapeutics's revenues are gauged from an analysis of company filings.



Lucy Therapeutics's Income Statement (based on Industry Averages)

Lucy Therapeutics P&L$ Millions
Revenue (Sales) Lucy Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Lucy Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 2, 2024 6 100%$11 MM
Complete list of funding rounds and total amounts in the Company Report




Market Share of Lucy Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lucy Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Lucy Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ELEVATEBIO IPSCWaltham, MA100 
IMMUNOGENWaltham, MA36 
BOSTON IVFWaltham, MA34 
NPS PHARMACEUTICALSLexington, MA32 
CLINICAL SERVICES CORPORATE OPERATIONSWaltham, MA20 
FOSTER-MILLERWaltham, MA15 




Future Competition: Lucy Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Lucy Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Lucy Therapeutics Competitors